GLP-1s were also tied to lower risks for preterm and cesarean births
Wegovy: A Powerful Weight Loss Drug for Adults with Obesity Wegovy (semaglutide injection 2.4 mg) is a higher-dose version of Ozempic, specifically approved for weight loss in adults with obesity or excess weight and at least one weight-related medical condition
Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg For adults with type 2 diabetes (T2D), along with diet and exercise to improve glycemic control, for adults with T2D and established CVD, to reduce risk of MACE (CV death, nonfatal MI, or nonfatal stroke), and for adults with T2D and chronic kidney disease, to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death
Food and Drug Administration (FDA) to treat epilepsy and prevent various types of seizures
Just fill out the application on their website
Common side effects of GLP-1 medications Understanding the most common GLP-1 side effects allows pharmacists to proactively counsel patients and set realistic expectations